中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2014年
8期
1152-1153
,共2页
心肌病,扩张型%卡维地洛
心肌病,擴張型%卡維地洛
심기병,확장형%잡유지락
Cardiomyopathy,dilated%Carvedilol
目的 观察卡维地洛治疗扩张型心肌病的临床疗效.方法 回顾性分析89例扩张型心肌病应用卡维地洛患者的临床资料.结果 总有效率98.88％,停药后死亡1例;治疗前、后左室腔收缩期内径(LVDD)分别为(68.25 ±2.15)mm、(56.89±4.21)mm,左室射血分数(LVEF)分别为(28.63±0.33)％、(40.56±3.98)％,差异均有统计学意义(t =7.215、16.877,均P＜0.05).结论 卡维地洛治疗扩张型心肌病临床效果较好.
目的 觀察卡維地洛治療擴張型心肌病的臨床療效.方法 迴顧性分析89例擴張型心肌病應用卡維地洛患者的臨床資料.結果 總有效率98.88％,停藥後死亡1例;治療前、後左室腔收縮期內徑(LVDD)分彆為(68.25 ±2.15)mm、(56.89±4.21)mm,左室射血分數(LVEF)分彆為(28.63±0.33)％、(40.56±3.98)％,差異均有統計學意義(t =7.215、16.877,均P＜0.05).結論 卡維地洛治療擴張型心肌病臨床效果較好.
목적 관찰잡유지락치료확장형심기병적림상료효.방법 회고성분석89례확장형심기병응용잡유지락환자적림상자료.결과 총유효솔98.88％,정약후사망1례;치료전、후좌실강수축기내경(LVDD)분별위(68.25 ±2.15)mm、(56.89±4.21)mm,좌실사혈분수(LVEF)분별위(28.63±0.33)％、(40.56±3.98)％,차이균유통계학의의(t =7.215、16.877,균P＜0.05).결론 잡유지락치료확장형심기병림상효과교호.
Objective To analyse the therapeutic effect of Carvedilol in patients with severe heart failure.Methods The clinical data of 89 Carvedilol patients treated with dilated cardiomyopathy were retrospective analysis.Results The overall therapeutic effective rate was 98.88％,because of one death related to discontinued use of medication.Before and after treatment,systolic left ventricular cavity diameter (LVDD) were (68.25 ± 2.15) mm,(56.89 ±4.21) mm,respectively,and left ventricular ejection fraction(LVEF) were (28.63 ±0.33)％,(40.56 ±3.98) ％,respectively,there were significantly differences (t =7.215,16.877,all P ＜ 0.05).Conclusion Carvedilol is the cornerstone in the drug treatments of patients with dilated cardiomyopathy.
